Since the serendipitous discovery of cisplatin, thousands of inorganic molecules have been synthesized in search of new drugs endowed with powerful anticancer activity and safe profile. As matter of fact, this “magic” and desired combination to date remains unmet. On the other side, after cisplatin, only two additional platinum-based drugs -that have been substantially designed as cisplatin-like molecules- have been approved at the global level, i.e., carboplatin and oxaliplatin. Accordingly, here, we try to summarize and highlight some relevant reasons for this “lack” of newly approved molecules. Also, we try to rationalize what are the critical steps in the discovery process (and approval) of new ameliorated anticancer metallodrugs, contributing to stimulate an open and critical scientific debate.

Is the Next Cisplatin Already in Our Laboratory?

Cirri D.
Primo
Writing – Review & Editing
;
Chiaverini L.
Secondo
Writing – Review & Editing
;
Pratesi A.
Penultimo
Writing – Review & Editing
;
Marzo T.
Ultimo
Writing – Original Draft Preparation
2022-01-01

Abstract

Since the serendipitous discovery of cisplatin, thousands of inorganic molecules have been synthesized in search of new drugs endowed with powerful anticancer activity and safe profile. As matter of fact, this “magic” and desired combination to date remains unmet. On the other side, after cisplatin, only two additional platinum-based drugs -that have been substantially designed as cisplatin-like molecules- have been approved at the global level, i.e., carboplatin and oxaliplatin. Accordingly, here, we try to summarize and highlight some relevant reasons for this “lack” of newly approved molecules. Also, we try to rationalize what are the critical steps in the discovery process (and approval) of new ameliorated anticancer metallodrugs, contributing to stimulate an open and critical scientific debate.
2022
Cirri, D.; Chiaverini, L.; Pratesi, A.; Marzo, T.
File in questo prodotto:
File Dimensione Formato  
Is the next cisplatin already in our laboratory_Post print.pdf

Open Access dal 30/11/2023

Descrizione: Is the Next Cisplatin Already in Our Laboratory
Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 233.96 kB
Formato Adobe PDF
233.96 kB Adobe PDF Visualizza/Apri
Is the Next Cisplatin Already in Our Laboratory.pdf

non disponibili

Descrizione: Editorial version
Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - accesso privato/ristretto
Dimensione 1.96 MB
Formato Adobe PDF
1.96 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/1160095
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact